SOTERA HEALTH CO (SHC)
US83601L1026 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to SHC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.78. This target is 38.67% above the current price.
SHC was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SHC.
In the previous month the buy percentage consensus was at a similar level.
SHC was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-06 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-06 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-21 | Piper Sandler | Initiate | Neutral |
| 2024-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2024-04-03 | Citigroup | Upgrade | Neutral -> Buy |
| 2024-03-25 | Jefferies | Upgrade | Hold -> Buy |
| 2024-03-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-06 | Keybanc | Initiate | Sector Weight |
| 2024-01-25 | Barclays | Maintains | Overweight -> Overweight |
| 2023-11-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-02 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-04 | Keybanc | Maintains | Overweight -> Overweight |
| 2023-08-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-06-26 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2023-06-22 | Keybanc | Maintains | Sector Weight |
| 2023-05-04 | RBC Capital | Maintains | Outperform |
| 2023-05-04 | Barclays | Maintains | Overweight |
| 2023-04-04 | Barclays | Maintains | Overweight |
| 2023-03-01 | RBC Capital | Maintains | Outperform |
| 2023-01-23 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2023-01-11 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2023-01-11 | Barclays | Upgrade | Underweight -> Overweight |
| 2022-11-23 | Goldman Sachs | Maintains | Neutral |
| 2022-11-16 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2022-11-15 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2022-11-03 | RBC Capital | Maintains | Outperform |